Investigating Engagement Patterns and Participation Trends Among Liposarcoma Patients
Launched by POWER LIFE SCIENCES INC. · Sep 8, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding the experiences of patients with liposarcoma, a type of cancer that affects soft tissue. The study aims to explore how often patients complete a specific clinical research trial and why some may choose to withdraw from it. By participating, individuals will not only share their valuable insights but also help improve treatment options and support for future liposarcoma patients.
To be eligible for this study, participants must be at least 18 years old and have been diagnosed with liposarcoma. They should also be planning to enroll in a clinical research trial. However, individuals who are pregnant, unable to understand or sign the consent form, or who cannot regularly report their progress electronically will not be able to participate. This trial is not yet recruiting, but it offers a chance for participants to play an important role in advancing medical knowledge and improving care for others facing this condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient has self-identified as planning to enroll in a clinical research
- • Patient has been diagnosed with liposarcoma
- • Patient is a minimum of 18 years or older
- Exclusion Criteria:
- • Patient does not understand, sign, and return consent form
- • Inability to perform regular electronic reporting
- • Patient is pregnant
About Power Life Sciences Inc.
Power Life Sciences Inc. is a forward-thinking clinical trial sponsor dedicated to advancing innovative therapeutic solutions across various medical disciplines. With a strong emphasis on scientific rigor and patient-centered approaches, the organization collaborates with leading researchers and healthcare professionals to design and execute clinical trials that prioritize safety, efficacy, and compliance. Power Life Sciences Inc. leverages cutting-edge technology and data analytics to streamline trial processes, enhance participant engagement, and accelerate the development of life-changing treatments, ultimately aiming to improve patient outcomes and contribute to the global healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Francisco, California, United States
Patients applied
Trial Officials
Michael B Gill
Study Director
Power Life Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported